临床诊断

路明克斯公司的xTAG™ 和 MultiCode®-RTx 技术灵敏度及准确性高,应用领域广泛,适用于高通量及高速度的检测。
 
 
 
了解更多

科学研究

您对自行研发以满足实验需求及技术指标感兴趣吗?路明克斯公司的xMAP®技术可以为您的多重检测提供一个灵活及应用广泛的平台。
 
 
 
了解更多

Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
 
了解更多

Luminex Blog

The Faces of Luminex: Kurt Hoffacker, Chemistry R&D

Developing immunoassay technology and platforms takes innovation and hard work on a number of fronts—hardware, software, reagents, and more. We count on Kurt Hoffacker, Director of Chemistry R&D, to ensure that reagent development goes smoothly, and ultimately leads to products that integrate well with the rest of the Luminex systems. He has been a key member of our chemistry team since 1999.

Continue Reading >

xMAP TECHNOLOGY OVERVIEW

 

 

xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.

Luminex on Twitter


RT @Luminex: As part of our ongoing commitment to provide our customers with flexible solutions for their current workflows, effective toda…
h J R
RT @statesman: Austin-based Luminex receives FDA approval for coronavirus test https://t.co/BtPf5rSe4l
h J R

Latest News

March 27th
Luminex Receives FDA Emergency Use Authorization for NxTAG® CoV Extended Panel to Detect the SARS-CoV-2 Virus that Causes COVID-19 Disease

March 13th
Luminex Provides Update on SARS-CoV-2 Validation Testing Efforts

March 4th
Luminex Provides Updates on Critical Efforts Related to Novel Coronavirus

Events

AACR Annual Meeting
April 24-29
San Diego, CA

Clinical Virology Symposium (CVS)
May 3-6
West Palm Beach, FL

Immunology
May 8-12
Honolulu, HI